FIELD: medicine, hematology. SUBSTANCE: invention proposes a method of inhibition of T-lympholeukosis process in animals. Method involves subcutaneous administration of a mixture in the dose 0.2 ml comprising, mmole/kg of weight: adenosine triphosphoric, acid 0.1; adenosine-3',5'-mono-phosphoric acid, 0.1; oxidized glutathione, 0.05; theophylline, 0.05; ethylenediamine, 0.01; 2-S-thiuronioethylidene-1,1-diphosphonic acid, 0.1; 1-β-D-arabinofuranosylcytosine 0.17, once per 10-14 days being all substances are dissolved in RPMI medium adding 0.2-0.3 N sodium hydroxide to pH = 5.6-6.5 and theophylline and ethylenediamine are used in the composition of 2.4% euphylline. EFFECT: enhanced effectiveness of treatment of T-lympholeukosis. 1 tbl, 5 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR REDUCTION OF TRUNCAL HEMOPOIETIC CELL OF IRRADIATED ANIMALS AND ITS VARIANTS | 1991 |
|
RU2017494C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES IN EXPERIMENT | 2007 |
|
RU2396967C2 |
METHOD FOR APPLYING VACCINE THERAPY FOR TREATING ONCOLOGIC DISEASES | 2000 |
|
RU2192883C2 |
MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
METHOD OF COLD-ASSISTED STIMULATION HUMORAL AND CELLULAR IMMUNITY | 1996 |
|
RU2142809C1 |
METHOD OF PREPARING THE BONE-MARROW INHIBITOR OF THE STEM HEMOPOIETIC CELL PROLIFERATION | 1994 |
|
RU2110268C1 |
PREPARATION INCREASING ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF CYCLOPHOSPHAN | 2002 |
|
RU2225720C1 |
MEDICATION, REDUCING HEMATOTOXICITY OF CYTOSTATICS | 2009 |
|
RU2397774C1 |
MEDICINAL AGENT STIMULATING ERYTHROID AND GRANULOCYTE ERYTHROPOIESIS STEMS AT CYTOSTATIC MYELODEPRESSIONS | 1993 |
|
RU2083201C1 |
METHOD FOR PREDICTING DEVELOPMENT OF INFECTION AND SEVERE INFECTIOUS COMPLICATIONS IN PATIENTS SUFFERING FROM HEMOBLASTOSIS RECEIVING PROGRAMMED POLYCHEMIOTHERAPY | 2000 |
|
RU2199115C2 |
Authors
Dates
2002-07-20—Published
2000-04-10—Filed